{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:01:58Z","timestamp":1780066918823,"version":"3.54.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T00:00:00Z","timestamp":1710633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T00:00:00Z","timestamp":1710633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MUR","award":["Progetto Eccellenza (2023-2027)"],"award-info":[{"award-number":["Progetto Eccellenza (2023-2027)"]}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>As reported in patients treated for androgenetic alopecia with finasteride (i.e., a blocker of the enzyme 5\u00a0alpha-reductase) and in an animal model, side effects affecting sexual, psychiatric, neurological, and physical domains, may occur during the treatment and persist with drug suspension. The etiopathogenesis of these side effects has been poorly explored. Therefore, we performed a genome-wide analysis of finasteride effects in the brain of adult male rat.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Animals were treated (i.e., for 20 days) with finasteride (1mg\/rat\/day). 24 h after the last treatment and 1 month after drug suspension, RNA sequencing analysis was performed in hypothalamus and hippocampus. Data were analyzed by differential expression analysis and Gene-Set Enrichment Analyses (GSEA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Data obtained after finasteride treatment showed that 186 genes (i.e., 171 up- and 15 downregulated) and 19 (i.e., 17 up- and 2 downregulated) were differentially expressed in the hypothalamus and hippocampus, respectively. Differential expression analysis at the drug withdrawal failed to identify dysregulated genes. Several gene-sets were enriched in these brain areas at both time points.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Some of the genes reported to be differentially expressed (i.e., <jats:italic>TTR<\/jats:italic><jats:italic>, <\/jats:italic><jats:italic>DIO2<\/jats:italic><jats:italic>, <\/jats:italic><jats:italic>CLDN1<\/jats:italic><jats:italic>, <\/jats:italic><jats:italic>CLDN2<\/jats:italic><jats:italic>, <\/jats:italic><jats:italic>SLC4A5, KCNE2, CROT, HCRT, MARCKSL1, VGF, IRF2BPL<\/jats:italic>) and GSEA, suggest a potential link with specific side effects previously observed in patients and in the animal model, such as depression, anxiety, disturbance in memory and attention, and sleep disturbance. These data may provide an important background for future experiments aimed at confirming the pathological role of these genes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-024-02345-y","type":"journal-article","created":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T04:16:43Z","timestamp":1710649003000},"page":"2565-2574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Analysis of the finasteride treatment and its withdrawal in the rat hypothalamus and hippocampus at whole-transcriptome level"],"prefix":"10.1007","volume":"47","author":[{"given":"S.","family":"Giatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cioffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Diviccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0861-8967","authenticated-orcid":false,"given":"R. C.","family":"Melcangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,17]]},"reference":[{"key":"2345_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70007-6","author":"KD Kaufman","year":"1998","unstructured":"Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ (1998) Finasteride in the treatment of men with androgenetic alopecia finasteride male pattern hair loss study group. J Am Acad Dermatol. https:\/\/doi.org\/10.1016\/S0190-9622(98)70007-6","journal-title":"J Am Acad Dermatol"},{"key":"2345_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2490-2-14","volume":"2","author":"JE Edwards","year":"2002","unstructured":"Edwards JE, Moore RA (2002) Finasteride in the treatment of clinical benign prostatic hyperplasia: a systematic review of randomised trials. BMC Urol 2:14","journal-title":"BMC Urol"},{"issue":"6","key":"2345_CR3","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.juro.2013.12.014","volume":"191","author":"CW Fwu","year":"2014","unstructured":"Fwu CW, Eggers PW, Kirkali Z, McVary KT, Burrows PK, Kusek JW (2014) Change in sexual function in men with lower urinary tract symptoms\/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy. J Urol 191(6):1828\u20131834. https:\/\/doi.org\/10.1016\/j.juro.2013.12.014","journal-title":"J Urol"},{"key":"2345_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11154-015-9319-y","volume":"16","author":"AM Traish","year":"2015","unstructured":"Traish AM, Melcangi RC, Bortolato M, Garcia-Segura LM, Zitzmann M (2015) Adverse effects of 5alpha-reductase inhibitors: What do we know, don\u2019t know, and need to know? Rev Endocr Metab Disord 16:177\u2013198. https:\/\/doi.org\/10.1007\/s11154-015-9319-y","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"2345_CR5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1001\/jamadermatol.2015.36","volume":"151","author":"SM Belknap","year":"2015","unstructured":"Belknap SM, Aslam I, Kiguradze T, Temps WH, Yarnold PR, Cashy J, Brannigan RE, Micali G, Nardone B, West DP (2015) Adverse event reporting in clinical trials of finasteride for androgenic alopecia: a meta-analysis. JAMA Dermatol 151(6):600\u2013606. https:\/\/doi.org\/10.1001\/jamadermatol.2015.36","journal-title":"JAMA Dermatol"},{"key":"2345_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2019.100209","volume":"12","author":"S Diviccaro","year":"2020","unstructured":"Diviccaro S, Melcangi RC, Giatti S (2020) Post-finasteride syndrome: an emerging clinical problem. Neurobiol Stress 12:100209. https:\/\/doi.org\/10.1016\/j.ynstr.2019.100209","journal-title":"Neurobiol Stress"},{"key":"2345_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11580.x","author":"IG Motofei","year":"2013","unstructured":"Motofei IG, Rowland DL, Georgescu SR, Baconi DL, Dimcevici NP, Paunica S, Constantin VD, Balalau C (2013) A pilot study on the sexual side effects of finasteride as related to hand preference for men undergoing treatment of male pattern baldness. BJU Int. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11580.x","journal-title":"BJU Int"},{"key":"2345_CR8","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2016.1161155","author":"IG Motofei","year":"2016","unstructured":"Motofei IG, Rowland DL, Georgescu SR, Tampa M, Baconi D, Stefanescu E, Baleanu BC, Balalau C, Constantin V, Paunica S (2016) Finasteride adverse effects in subjects with androgenic alopecia: a possible therapeutic approach according to the lateralization process of the brain. J Dermatol Treat. https:\/\/doi.org\/10.3109\/09546634.2016.1161155","journal-title":"J Dermatol Treat"},{"issue":"6","key":"2345_CR9","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/j.1743-6109.2011.02255.x","volume":"8","author":"MS Irwig","year":"2011","unstructured":"Irwig MS, Kolukula S (2011) Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med 8(6):1747\u20131753. https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02255.x","journal-title":"J Sex Med"},{"issue":"11","key":"2345_CR10","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1111\/j.1743-6109.2012.02846.x","volume":"9","author":"MS Irwig","year":"2012","unstructured":"Irwig MS (2012) Persistent sexual side effects of finasteride: could they be permanent? J Sex Med 9(11):2927\u20132932. https:\/\/doi.org\/10.1111\/j.1743-6109.2012.02846.x","journal-title":"J Sex Med"},{"issue":"3","key":"2345_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/1557988314538445","volume":"9","author":"CA Ganzer","year":"2015","unstructured":"Ganzer CA, Jacobs AR, Iqbal F (2015) Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms. Am J Mens Health 9(3):222\u2013228. https:\/\/doi.org\/10.1177\/1557988314538445","journal-title":"Am J Mens Health"},{"issue":"12","key":"2345_CR12","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1210\/jc.2016-2726","volume":"101","author":"S Basaria","year":"2016","unstructured":"Basaria S, Jasuja R, Huang G, Wharton W, Pan H, Pencina K, Li Z, Travison TG, Bhawan J, Gonthier R, Labrie F, Dury AY, Serra C, Papazian A, O\u2019Leary M, Amr S, Storer TW, Stern E, Bhasin S (2016) Characteristics of men who report persistent sexual symptoms after finasteride use for hair loss. J Clin Endocrinol Metab 101(12):4669\u20134680. https:\/\/doi.org\/10.1210\/jc.2016-2726","journal-title":"J Clin Endocrinol Metab"},{"key":"2345_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jsbmb.2017.04.003","volume":"171","author":"RC Melcangi","year":"2017","unstructured":"Melcangi RC, Santi D, Spezzano R, Grimoldi M, Tabacchi T, Fusco ML, Diviccaro S, Giatti S, Carra G, Caruso D, Simoni M, Cavaletti G (2017) Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients. J Steroid Biochem Mol Biol 171:229\u2013235. https:\/\/doi.org\/10.1016\/j.jsbmb.2017.04.003","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"2345_CR14","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.21037\/tau.2020.03.21","volume":"9","author":"M Khera","year":"2020","unstructured":"Khera M, Than JK, Anaissie J, Antar A, Song W, Losso B, Pastuszak A, Kohn T, Mirabal JR (2020) Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia. Transl Androl Urol 9(3):1201\u20131209. https:\/\/doi.org\/10.21037\/tau.2020.03.21","journal-title":"Transl Androl Urol"},{"issue":"10","key":"2345_CR15","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1111\/jsm.12269","volume":"10","author":"RC Melcangi","year":"2013","unstructured":"Melcangi RC, Caruso D, Abbiati F, Giatti S, Calabrese D, Piazza F, Cavaletti G (2013) Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious\/depressive symptomatology. J Sex Med 10(10):2598\u20132603. https:\/\/doi.org\/10.1111\/jsm.12269","journal-title":"J Sex Med"},{"key":"2345_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jsbmb.2014.03.012","volume":"146","author":"D Caruso","year":"2015","unstructured":"Caruso D, Abbiati F, Giatti S, Romano S, Fusco L, Cavaletti G, Melcangi RC (2015) Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma. J Steroid Biochem Mol Biol 146:74\u201379. https:\/\/doi.org\/10.1016\/j.jsbmb.2014.03.012","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"2345_CR17","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1159\/000442982","volume":"103","author":"S Giatti","year":"2016","unstructured":"Giatti S, Foglio B, Romano S, Pesaresi M, Panzica G, Garcia-Segura LM, Caruso D, Melcangi RC (2016) Effects of subchronic finasteride treatment and withdrawal on neuroactive steroid levels and their receptors in the male rat brain. Neuroendocrinology 103(6):746\u2013757. https:\/\/doi.org\/10.1159\/000442982","journal-title":"Neuroendocrinology"},{"issue":"6","key":"2345_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100237","volume":"9","author":"C Di Loreto","year":"2014","unstructured":"Di Loreto C, La Marra F, Mazzon G, Belgrano E, Trombetta C, Cauci S (2014) Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia. PLoS ONE 9(6):e100237. https:\/\/doi.org\/10.1371\/journal.pone.0100237","journal-title":"PLoS ONE"},{"issue":"4","key":"2345_CR19","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.5301\/jbm.5000095","volume":"29","author":"E Cecchin","year":"2014","unstructured":"Cecchin E, De Mattia E, Mazzon G, Cauci S, Trombetta C, Toffoli G (2014) A pharmacogenetic survey of androgen receptor (CAG)n and (GGN)n polymorphisms in patients experiencing long term side effects after finasteride discontinuation. Int J Biol Markers 29(4):e310-316. https:\/\/doi.org\/10.5301\/jbm.5000095","journal-title":"Int J Biol Markers"},{"issue":"1","key":"2345_CR20","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.esxm.2016.11.001","volume":"5","author":"S Cauci","year":"2017","unstructured":"Cauci S, Chiriaco G, Cecchin E, Toffoli G, Xodo S, Stinco G, Trombetta C (2017) Androgen receptor (AR) gene (CAG)n and (GGN)n length polymorphisms and symptoms in young males with long-lasting adverse effects after finasteride use against androgenic alopecia. Sex Med 5(1):e61\u2013e71. https:\/\/doi.org\/10.1016\/j.esxm.2016.11.001","journal-title":"Sex Med"},{"key":"2345_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neubiorev.2015.09.023","volume":"67","author":"RC Melcangi","year":"2016","unstructured":"Melcangi RC, Giatti S, Garcia-Segura LM (2016) Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: sex-specific features. Neurosci Biobehav Rev 67:25\u201340. https:\/\/doi.org\/10.1016\/j.neubiorev.2015.09.023","journal-title":"Neurosci Biobehav Rev"},{"key":"2345_CR22","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s40618-020-01424-0","volume":"44","author":"F Borgo","year":"2020","unstructured":"Borgo F, Macandog AD, Diviccaro S, Falvo E, Giatti S, Cavaletti G, Melcangi RC (2020) Alterations of gut microbiota composition in post-finasteride patients: a pilot study. J Endocrinol Invest 44:1263\u20131273. https:\/\/doi.org\/10.1007\/s40618-020-01424-0","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"2345_CR23","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3390\/biom12111567","volume":"12","author":"S Diviccaro","year":"2022","unstructured":"Diviccaro S, Giatti S, Cioffi L, Falvo E, Herian M, Caruso D, Melcangi RC (2022) Gut Inflammation induced by finasteride withdrawal: therapeutic effect of allopregnanolone in adult male rats. Biomolecules 12(11):1567. https:\/\/doi.org\/10.3390\/biom12111567","journal-title":"Biomolecules"},{"key":"2345_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.psyneuen.2018.09.021","volume":"99","author":"S Diviccaro","year":"2019","unstructured":"Diviccaro S, Giatti S, Borgo F, Barcella M, Borghi E, Trejo JL, Garcia-Segura LM, Melcangi RC (2019) Treatment of male rats with finasteride, an inhibitor of 5alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota composition. Psychoneuroendocrinology 99:206\u2013215. https:\/\/doi.org\/10.1016\/j.psyneuen.2018.09.021","journal-title":"Psychoneuroendocrinology"},{"key":"2345_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/andr.13515","author":"S Diviccaro","year":"2023","unstructured":"Diviccaro S, Herian M, Cioffi L, Audano M, Mitro N, Caruso D, Giatti S, Melcangi RC (2023) Exploring rat corpus cavernosum alterations induced by finasteride treatment and withdrawal. Andrology. https:\/\/doi.org\/10.1111\/andr.13515","journal-title":"Andrology"},{"issue":"8","key":"2345_CR26","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.1021\/acs.jmedchem.0c02039","volume":"64","author":"S Giatti","year":"2021","unstructured":"Giatti S, Di Domizio A, Diviccaro S, Falvo E, Caruso D, Contini A, Melcangi RC (2021) Three-dimensional proteome-wide scale screening for the 5-alpha reductase inhibitor finasteride: identification of a novel off-target. J Med Chem 64(8):4553\u20134566. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c02039","journal-title":"J Med Chem"},{"issue":"9","key":"2345_CR27","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.jsxm.2021.05.009","volume":"18","author":"S Howell","year":"2021","unstructured":"Howell S, Song W, Pastuszak A, Khera M (2021) Differential gene expression in post-finasteride syndrome patients. J Sex Med 18(9):1479\u20131490. https:\/\/doi.org\/10.1016\/j.jsxm.2021.05.009","journal-title":"J Sex Med"},{"issue":"1","key":"2345_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1):15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635","journal-title":"Bioinformatics"},{"issue":"12","key":"2345_CR29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8","journal-title":"Genome Biol"},{"key":"2345_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","author":"P Danecek","year":"2021","unstructured":"Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, Whitwham A, Keane T, McCarthy SA, Davies RM, Li H (2021) Twelve years of SAMtools and BCFtools. Gigascience. https:\/\/doi.org\/10.1093\/gigascience\/giab008","journal-title":"Gigascience"},{"issue":"2","key":"2345_CR31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsdottir","year":"2013","unstructured":"Thorvaldsdottir H, Robinson JT, Mesirov JP (2013) Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14(2):178\u2013192. https:\/\/doi.org\/10.1093\/bib\/bbs017","journal-title":"Brief Bioinform"},{"issue":"10","key":"2345_CR32","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1523\/JNEUROSCI.6012-08.2009","volume":"29","author":"CE Fleming","year":"2009","unstructured":"Fleming CE, Mar FM, Franquinho F, Saraiva MJ, Sousa MM (2009) Transthyretin internalization by sensory neurons is megalin mediated and necessary for its neuritogenic activity. J Neurosci 29(10):3220\u20133232. https:\/\/doi.org\/10.1523\/JNEUROSCI.6012-08.2009","journal-title":"J Neurosci"},{"issue":"1\u20133","key":"2345_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000285513","volume":"7","author":"S Doggui","year":"2010","unstructured":"Doggui S, Brouillette J, Chabot JG, Farso M, Quirion R (2010) Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of alzheimer\u2019s disease (TgCRND8). Neurodegener Dis 7(1\u20133):88\u201395. https:\/\/doi.org\/10.1159\/000285513","journal-title":"Neurodegener Dis"},{"issue":"7","key":"2345_CR34","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.neuint.2009.07.001","volume":"55","author":"AF Nunes","year":"2009","unstructured":"Nunes AF, Montero M, Franquinho F, Santos SD, Malva J, Zimmer J, Sousa MM (2009) Transthyretin knockout mice display decreased susceptibility to AMPA-induced neurodegeneration. Neurochem Int 55(7):454\u2013457. https:\/\/doi.org\/10.1016\/j.neuint.2009.07.001","journal-title":"Neurochem Int"},{"issue":"3","key":"2345_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.nlm.2007.07.006","volume":"88","author":"JC Sousa","year":"2007","unstructured":"Sousa JC, Marques F, Dias-Ferreira E, Cerqueira JJ, Sousa N, Palha JA (2007) Transthyretin influences spatial reference memory. Neurobiol Learn Mem 88(3):381\u2013385. https:\/\/doi.org\/10.1016\/j.nlm.2007.07.006","journal-title":"Neurobiol Learn Mem"},{"issue":"4","key":"2345_CR36","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1460-9568.2009.06862.x","volume":"30","author":"I Fernandez-Lamo","year":"2009","unstructured":"Fernandez-Lamo I, Montero-Pedrazuela A, Delgado-Garcia JM, Guadano-Ferraz A, Gruart A (2009) Effects of thyroid hormone replacement on associative learning and hippocampal synaptic plasticity in adult hypothyroid rats. Eur J Neurosci 30(4):679\u2013692. https:\/\/doi.org\/10.1111\/j.1460-9568.2009.06862.x","journal-title":"Eur J Neurosci"},{"key":"2345_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2022.114175","volume":"357","author":"H Chang","year":"2022","unstructured":"Chang H, Lin C, Li Z, Shen Y, Zhang G, Mao L, Ma C, Liu N, Lu H (2022) T3 alleviates neuroinflammation and reduces early brain injury after subarachnoid haemorrhage by promoting mitophagy via PINK 1-parkin pathway. Exp Neurol 357:114175. https:\/\/doi.org\/10.1016\/j.expneurol.2022.114175","journal-title":"Exp Neurol"},{"issue":"2","key":"2345_CR38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/sj.mp.4000963","volume":"7","author":"M Bauer","year":"2002","unstructured":"Bauer M, Heinz A, Whybrow PC (2002) Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol Psychiatry 7(2):140\u2013156. https:\/\/doi.org\/10.1038\/sj.mp.4000963","journal-title":"Mol Psychiatry"},{"issue":"1\u20132","key":"2345_CR39","first-page":"45","volume":"8","author":"RT Joffe","year":"1994","unstructured":"Joffe RT, Sokolov ST (1994) Thyroid hormones, the brain, and affective disorders. Crit Rev Neurobiol 8(1\u20132):45\u201363","journal-title":"Crit Rev Neurobiol"},{"key":"2345_CR40","doi-asserted-by":"publisher","first-page":"1240265","DOI":"10.3389\/fendo.2023.1240265","volume":"14","author":"N Chakrabarti","year":"2023","unstructured":"Chakrabarti N, Sarkar PK, Ray AK, Martin JV (2023) Unveiling the nongenomic actions of thyroid hormones in adult mammalian brain: the legacy of Mary B Dratman. Front Endocrinol (Lausanne) 14:1240265. https:\/\/doi.org\/10.3389\/fendo.2023.1240265","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2345_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13010022","author":"M Murolo","year":"2022","unstructured":"Murolo M, Di Vincenzo O, Cicatiello AG, Scalfi L, Dentice M (2022) Cardiovascular and neuronal consequences of thyroid hormones alterations in the ischemic stroke. Metabolites. https:\/\/doi.org\/10.3390\/metabo13010022","journal-title":"Metabolites"},{"issue":"7","key":"2345_CR42","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1210\/en.2006-1727","volume":"148","author":"VA Galton","year":"2007","unstructured":"Galton VA, Wood ET, St Germain EA, Withrow CA, Aldrich G, St Germain GM, Clark AS, St Germain DL (2007) Thyroid hormone homeostasis and action in the type 2 deiodinase-deficient rodent brain during development. Endocrinology 148(7):3080\u20133088. https:\/\/doi.org\/10.1210\/en.2006-1727","journal-title":"Endocrinology"},{"issue":"6","key":"2345_CR43","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1210\/en.2008-1572","volume":"150","author":"VA Galton","year":"2009","unstructured":"Galton VA, Schneider MJ, Clark AS, St Germain DL (2009) Life without thyroxine to 3,5,3\u2032-triiodothyronine conversion: studies in mice devoid of the 5\u2032-deiodinases. Endocrinology 150(6):2957\u20132963. https:\/\/doi.org\/10.1210\/en.2008-1572","journal-title":"Endocrinology"},{"issue":"8","key":"2345_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103857","volume":"9","author":"S Barez-Lopez","year":"2014","unstructured":"Barez-Lopez S, Bosch-Garcia D, Gomez-Andres D, Pulido-Valdeolivas I, Montero-Pedrazuela A, Obregon MJ, Guadano-Ferraz A (2014) Abnormal motor phenotype at adult stages in mice lacking type 2 deiodinase. PLoS ONE 9(8):e103857. https:\/\/doi.org\/10.1371\/journal.pone.0103857","journal-title":"PLoS ONE"},{"key":"2345_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.psyneuen.2017.06.013","volume":"84","author":"S Barez-Lopez","year":"2017","unstructured":"Barez-Lopez S, Montero-Pedrazuela A, Bosch-Garcia D, Venero C, Guadano-Ferraz A (2017) Increased anxiety and fear memory in adult mice lacking type 2 deiodinase. Psychoneuroendocrinology 84:51\u201360. https:\/\/doi.org\/10.1016\/j.psyneuen.2017.06.013","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"2345_CR46","doi-asserted-by":"publisher","first-page":"C1213","DOI":"10.1152\/ajpcell.00558.2003","volume":"286","author":"EE Schneeberger","year":"2004","unstructured":"Schneeberger EE, Lynch RD (2004) The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 286(6):C1213-1228. https:\/\/doi.org\/10.1152\/ajpcell.00558.2003","journal-title":"Am J Physiol Cell Physiol"},{"issue":"11","key":"2345_CR47","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/tra.12685","volume":"20","author":"V Tikiyani","year":"2019","unstructured":"Tikiyani V, Babu K (2019) Claudins in the brain: unconventional functions in neurons. Traffic 20(11):807\u2013814. https:\/\/doi.org\/10.1111\/tra.12685","journal-title":"Traffic"},{"issue":"5","key":"2345_CR48","doi-asserted-by":"publisher","first-page":"R2136","DOI":"10.1152\/ajpregu.00356.2007","volume":"293","author":"HH Damkier","year":"2007","unstructured":"Damkier HH, Nielsen S, Praetorius J (2007) Molecular expression of SLC4-derived Na+-dependent anion transporters in selected human tissues. Am J Physiol Regul Integr Comp Physiol 293(5):R2136-2146. https:\/\/doi.org\/10.1152\/ajpregu.00356.2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2345_CR49","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fphys.2013.00304","volume":"4","author":"HL Christensen","year":"2013","unstructured":"Christensen HL, Nguyen AT, Pedersen FD, Damkier HH (2013) Na(+) dependent acid-base transporters in the choroid plexus; insights from slc4 and slc9 gene deletion studies. Front Physiol 4:304. https:\/\/doi.org\/10.3389\/fphys.2013.00304","journal-title":"Front Physiol"},{"issue":"37","key":"2345_CR50","doi-asserted-by":"publisher","first-page":"32563","DOI":"10.1074\/jbc.M111.249961","volume":"286","author":"L Kao","year":"2011","unstructured":"Kao L, Kurtz LM, Shao X, Papadopoulos MC, Liu L, Bok D, Nusinowitz S, Chen B, Stella SL, Andre M, Weinreb J, Luong SS, Piri N, Kwong JM, Newman D, Kurtz I (2011) Severe neurologic impairment in mice with targeted disruption of the electrogenic sodium bicarbonate cotransporter NBCe2 (Slc4a5 gene). J Biol Chem 286(37):32563\u201332574. https:\/\/doi.org\/10.1074\/jbc.M111.249961","journal-title":"J Biol Chem"},{"key":"2345_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2005025","author":"GW Abbott","year":"2014","unstructured":"Abbott GW, Tai KK, Neverisky DL, Hansler A, Hu Z, Roepke TK, Lerner DJ, Chen Q, Liu L, Zupan B, Toth M, Haynes R, Huang X, Demirbas D, Buccafusca R, Gross SS, Kanda VA, Berry GT (2014) KCNQ1, KCNE2, and Na+-coupled solute transporters form reciprocally regulating complexes that affect neuronal excitability. Sci Signal. https:\/\/doi.org\/10.1126\/scisignal.2005025","journal-title":"Sci Signal"},{"issue":"4","key":"2345_CR52","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.bbrc.2011.05.068","volume":"409","author":"F Le Borgne","year":"2011","unstructured":"Le Borgne F, Ben Mohamed A, Logerot M, Garnier E, Demarquoy J (2011) Changes in carnitine octanoyltransferase activity induce alteration in fatty acid metabolism. Biochem Biophys Res Commun 409(4):699\u2013704. https:\/\/doi.org\/10.1016\/j.bbrc.2011.05.068","journal-title":"Biochem Biophys Res Commun"},{"key":"2345_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.536682","volume":"14","author":"J Rose","year":"2020","unstructured":"Rose J, Brian C, Pappa A, Panayiotidis MI, Franco R (2020) Mitochondrial metabolism in astrocytes regulates brain bioenergetics. Neurotransmission Redox Balance Front Neurosci 14:536682. https:\/\/doi.org\/10.3389\/fnins.2020.536682","journal-title":"Neurotransmission Redox Balance Front Neurosci"},{"key":"2345_CR54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.biochi.2013.09.009","volume":"98","author":"D Trompier","year":"2014","unstructured":"Trompier D, Vejux A, Zarrouk A, Gondcaille C, Geillon F, Nury T, Savary S, Lizard G (2014) Brain peroxisomes. Biochimie 98:102\u2013110. https:\/\/doi.org\/10.1016\/j.biochi.2013.09.009","journal-title":"Biochimie"},{"key":"2345_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2023.101066","volume":"69","author":"M Ten-Blanco","year":"2023","unstructured":"Ten-Blanco M, Flores A, Cristino L, Pereda-Perez I, Berrendero F (2023) Targeting the orexin\/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: from animal to clinical studies. Front Neuroendocrinol 69:101066. https:\/\/doi.org\/10.1016\/j.yfrne.2023.101066","journal-title":"Front Neuroendocrinol"},{"issue":"4","key":"2345_CR56","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s0092-8674(00)81973-x","volume":"98","author":"RM Chemelli","year":"1999","unstructured":"Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98(4):437\u2013451. https:\/\/doi.org\/10.1016\/s0092-8674(00)81973-x","journal-title":"Cell"},{"issue":"3","key":"2345_CR57","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/s0092-8674(00)81965-0","volume":"98","author":"L Lin","year":"1999","unstructured":"Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98(3):365\u2013376. https:\/\/doi.org\/10.1016\/s0092-8674(00)81965-0","journal-title":"Cell"},{"issue":"9","key":"2345_CR58","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/79690","volume":"6","author":"C Peyron","year":"2000","unstructured":"Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6(9):991\u2013997. https:\/\/doi.org\/10.1038\/79690","journal-title":"Nat Med"},{"issue":"3","key":"2345_CR59","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/s0896-6273(00)00058-1","volume":"27","author":"TC Thannickal","year":"2000","unstructured":"Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27(3):469\u2013474. https:\/\/doi.org\/10.1016\/s0896-6273(00)00058-1","journal-title":"Neuron"},{"issue":"9197","key":"2345_CR60","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","volume":"355","author":"S Nishino","year":"2000","unstructured":"Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355(9197):39\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(99)05582-8","journal-title":"Lancet"},{"issue":"13","key":"2345_CR61","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1073\/pnas.0400590101","volume":"101","author":"M Mieda","year":"2004","unstructured":"Mieda M, Willie JT, Hara J, Sinton CM, Sakurai T, Yanagisawa M (2004) Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci U S A 101(13):4649\u20134654. https:\/\/doi.org\/10.1073\/pnas.0400590101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"2345_CR62","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.1523\/JNEUROSCI.6506-10.2011","volume":"31","author":"M Mieda","year":"2011","unstructured":"Mieda M, Hasegawa E, Kisanuki YY, Sinton CM, Yanagisawa M, Sakurai T (2011) Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep. J Neurosci 31(17):6518\u20136526. https:\/\/doi.org\/10.1523\/JNEUROSCI.6506-10.2011","journal-title":"J Neurosci"},{"issue":"3","key":"2345_CR63","first-page":"313","volume":"139","author":"MM Thakkar","year":"2001","unstructured":"Thakkar MM, Ramesh V, Strecker RE, McCarley RW (2001) Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch Ital Biol 139(3):313\u2013328","journal-title":"Arch Ital Biol"},{"key":"2345_CR64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ebiom.2018.03.018","volume":"30","author":"T Tanaka","year":"2018","unstructured":"Tanaka T, Shimizu S, Ueno M, Fujihara Y, Ikawa M, Miyata S (2018) MARCKSL1 regulates spine formation in the amygdala and controls the hypothalamic-pituitary-adrenal axis and anxiety-like behaviors. EBioMedicine 30:62\u201373. https:\/\/doi.org\/10.1016\/j.ebiom.2018.03.018","journal-title":"EBioMedicine"},{"issue":"1","key":"2345_CR65","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/(SICI)1096-9861(19980427)394:1<91::AID-CNE7>3.0.CO;2-C","volume":"394","author":"SE Snyder","year":"1998","unstructured":"Snyder SE, Salton SR (1998) Expression of VGF mRNA in the adult rat central nervous system. J Comp Neurol 394(1):91\u2013105","journal-title":"J Comp Neurol"},{"issue":"3","key":"2345_CR66","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/cne.903470311","volume":"347","author":"AN van den Pol","year":"1994","unstructured":"van den Pol AN, Bina K, Decavel C, Ghosh P (1994) VGF expression in the brain. J Comp Neurol 347(3):455\u2013469. https:\/\/doi.org\/10.1002\/cne.903470311","journal-title":"J Comp Neurol"},{"issue":"1","key":"2345_CR67","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1038\/s41598-017-04132-7","volume":"7","author":"T Mizoguchi","year":"2017","unstructured":"Mizoguchi T, Minakuchi H, Ishisaka M, Tsuruma K, Shimazawa M, Hara H (2017) Behavioral abnormalities with disruption of brain structure in mice overexpressing VGF. Sci Rep 7(1):4691. https:\/\/doi.org\/10.1038\/s41598-017-04132-7","journal-title":"Sci Rep"},{"issue":"3","key":"2345_CR68","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ajhg.2018.08.010","volume":"103","author":"PC Marcogliese","year":"2018","unstructured":"Marcogliese PC, Shashi V, Spillmann RC, Stong N, Rosenfeld JA, Koenig MK, Martinez-Agosto JA, Herzog M, Chen AH, Dickson PI, Lin HJ, Vera MU, Salamon N, Graham JM Jr, Ortiz D, Infante E, Steyaert W, Dermaut B, Poppe B, Chung HL, Zuo Z, Lee PT, Kanca O, Xia F, Yang Y, Smith EC, Jasien J, Kansagra S, Spiridigliozzi G, El-Dairi M, Lark R, Riley K, Koeberl DD, Golden-Grant K, Program for Undiagnosed D, Undiagnosed Diseases N, Yamamoto S, Wangler MF, Mirzaa G, Hemelsoet D, Lee B, Nelson SF, Goldstein DB, Bellen HJ, Pena LDM, (2018) IRF2BPL is associated with Neurological phenotypes. Am J Hum Genet 103(3):456. https:\/\/doi.org\/10.1016\/j.ajhg.2018.08.010","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2345_CR69","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ajhg.2018.07.006","volume":"103","author":"PC Marcogliese","year":"2018","unstructured":"Marcogliese PC, Shashi V, Spillmann RC, Stong N, Rosenfeld JA, Koenig MK, Martinez-Agosto JA, Herzog M, Chen AH, Dickson PI, Lin HJ, Vera MU, Salamon N, Graham JM Jr, Ortiz D, Infante E, Steyaert W, Dermaut B, Poppe B, Chung HL, Zuo Z, Lee PT, Kanca O, Xia F, Yang Y, Smith EC, Jasien J, Kansagra S, Spiridigliozzi G, El-Dairi M, Lark R, Riley K, Koeberl DD, Golden-Grant K, Program for Undiagnosed D, Undiagnosed Diseases N, Yamamoto S, Wangler MF, Mirzaa G, Hemelsoet D, Lee B, Nelson SF, Goldstein DB, Bellen HJ, Pena LDM, (2018) IRF2BPL Is Associated with Neurological phenotypes. Am J Hum Genet 103(2):245\u2013260. https:\/\/doi.org\/10.1016\/j.ajhg.2018.07.006","journal-title":"Am J Hum Genet"},{"key":"2345_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2022.100534","volume":"26","author":"YJ Li","year":"2022","unstructured":"Li YJ, Kresock E, Kuplicki R, Savitz J, McKinney BA (2022) Differential expression of MDGA1 in major depressive disorder. Brain Behav Immun Health 26:100534. https:\/\/doi.org\/10.1016\/j.bbih.2022.100534","journal-title":"Brain Behav Immun Health"},{"issue":"1","key":"2345_CR71","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41398-020-01086-9","volume":"10","author":"A Vallee","year":"2020","unstructured":"Vallee A, Lecarpentier Y, Guillevin R, Vallee JN (2020) The influence of circadian rhythms and aerobic glycolysis in autism spectrum disorder. Transl Psychiatry 10(1):400. https:\/\/doi.org\/10.1038\/s41398-020-01086-9","journal-title":"Transl Psychiatry"},{"issue":"7113","key":"2345_CR72","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443(7113):787\u2013795. https:\/\/doi.org\/10.1038\/nature05292","journal-title":"Nature"},{"issue":"10","key":"2345_CR73","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/mp.2015.168","volume":"21","author":"JC Felger","year":"2016","unstructured":"Felger JC, Li Z, Haroon E, Woolwine BJ, Jung MY, Hu X, Miller AH (2016) Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry 21(10):1358\u20131365. https:\/\/doi.org\/10.1038\/mp.2015.168","journal-title":"Mol Psychiatry"},{"key":"2345_CR74","doi-asserted-by":"publisher","DOI":"10.1017\/s1092852900024901","author":"PH Reddy","year":"2009","unstructured":"Reddy PH (2009) Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer\u2019s disease. CNS Spectr. https:\/\/doi.org\/10.1017\/s1092852900024901","journal-title":"CNS Spectr"},{"issue":"1","key":"2345_CR75","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1460-9568.2011.07738.x","volume":"34","author":"A Salminen","year":"2011","unstructured":"Salminen A, Ojala J, Kaarniranta K, Haapasalo A, Hiltunen M, Soininen H (2011) Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype. Eur J Neurosci 34(1):3\u201311. https:\/\/doi.org\/10.1111\/j.1460-9568.2011.07738.x","journal-title":"Eur J Neurosci"},{"issue":"4","key":"2345_CR76","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri.2017.125","volume":"18","author":"Q Li","year":"2018","unstructured":"Li Q, Barres BA (2018) Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol 18(4):225\u2013242. https:\/\/doi.org\/10.1038\/nri.2017.125","journal-title":"Nat Rev Immunol"},{"issue":"6286","key":"2345_CR77","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, Lemere CA, Selkoe DJ, Stevens B (2016) Complement and microglia mediate early synapse loss in alzheimer mouse models. Science 352(6286):712\u2013716. https:\/\/doi.org\/10.1126\/science.aad8373","journal-title":"Science"},{"issue":"1","key":"2345_CR78","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neuron.2009.09.001","volume":"64","author":"LM Boulanger","year":"2009","unstructured":"Boulanger LM (2009) Immune proteins in brain development and synaptic plasticity. Neuron 64(1):93\u2013109. https:\/\/doi.org\/10.1016\/j.neuron.2009.09.001","journal-title":"Neuron"},{"issue":"4","key":"2345_CR79","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","volume":"6","author":"VH Perry","year":"2010","unstructured":"Perry VH, Nicoll JA, Holmes C (2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6(4):193\u2013201. https:\/\/doi.org\/10.1038\/nrneurol.2010.17","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"2345_CR80","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.pharmthera.2007.02.003","volume":"114","author":"CA McClung","year":"2007","unstructured":"McClung CA (2007) Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther 114(2):222\u2013232. https:\/\/doi.org\/10.1016\/j.pharmthera.2007.02.003","journal-title":"Pharmacol Ther"},{"issue":"9821","key":"2345_CR81","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(11)60750-2","volume":"379","author":"CM Morin","year":"2012","unstructured":"Morin CM, Benca R (2012) Chronic insomnia. Lancet 379(9821):1129\u20131141. https:\/\/doi.org\/10.1016\/S0140-6736(11)60750-2","journal-title":"Lancet"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02345-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02345-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02345-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T10:12:54Z","timestamp":1726135974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02345-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,17]]},"references-count":81,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["2345"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02345-y","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,17]]},"assertion":[{"value":"23 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study procedure was approved by the Ethics Committee of Universit\u00e0 degli Studi di Milano, Italy (authorization 1083\/2015-PR).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}